Obesity, Medicaid and Biden

Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity medications. But it's not clear if the proposed change will go into effect.
Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don’t work. So when the University of North Carolina-Charlotte professor learned that Ozempic — developed to treat Type 2 diabetes — helped people lose weight and keep it off,
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Biden to require Medicare and Medicaid to cover weight loss drugs
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and Medicaid. The move could potentially help some seven million Americans pay for the expensive drugs,
FiercePharma12h
Race is on for oral obesity drugs with multiple phase 3 trials vying for next-gen status in a $126B market
Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...
MarketWatch3h
Health Care Flat on Mixed Obesity-Drug Fortunes - Health Care Roundup
Recent data from an Amgen obesity-drug trial only reinforced investors' impressions that Eli Lilly and Novo Nordisk have a prohibitive head start, thanks, in particular, to a new generation of ...
New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
health.wusf.usf.edu11h
Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
The Associated Press - Business News on MSN10d
Even with access to blockbuster obesity drugs, some people don't lose weight
It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect ...
GLP-1s Are Popular Obesity Meds, But What Role Could Prevention Play In Revamped HHS?
Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...